Inspired by the connection between “BTZ, ROS, NF‐κB signal, and CSCs” and the crucial role of IL‐33 in ROS generation, we hypothesized that IL‐33 could enhance the sensitivity of MM cells to BTZ through ROS‐mediated inhibition of NF‐κB signal and stemness properties. This evidence concerns the gene IL33 and Miyoshi myopathy.